Work in our laboratory showed that platelets from DM patients with poor glycemic control express significantly higher levels of the pro-oxidant enzyme nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 1 (NOX1) (Figure 1). This evidence concerns the gene NOX1 and diabetes mellitus.